首頁 > 市場調查報告書 > 製藥

藥用甘油市場規模、佔有率及成長分析（按類型、原料、應用及地區分類）－2025-2032年產業預測

市場調查報告書

商品編碼

1878050

藥用甘油市場規模、佔有率及成長分析（按類型、原料、應用及地區分類）－2025-2032年產業預測

Pharmaceutical Glycerine Market Size, Share, and Growth Analysis, By Type (99.7% Purity, Above 99.7% Purity), By Source (Animal, Plant), By Application, By Region - Industry Forecast 2025-2032

出版日期: 2025年11月18日 | 出版商:

SkyQuest | 英文 186 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球藥用甘油市場規模將達到 3,850 萬美元，到 2025 年將成長至 4,108 萬美元，到 2033 年將成長至 6,901 萬美元，預測期（2026-2033 年）的複合年成長率為 6.7%。

全球藥用甘油市場正經歷顯著成長，這主要得益於其安全性和多功能性，使其在膠囊、糖漿和外用製劑等藥物製劑中的應用範圍不斷擴大。新興市場對止咳糖漿、創傷護理軟膏和甘油膠囊的需求不斷成長，推動了甘油的消費。製藥業的進步，尤其是在亞太和拉丁美洲地區，以及高純度甘油生產製程的改進，也為此成長提供了支持。消費者對植物來源甘油的日益青睞，進一步推動了向永續生物基材料的轉變。然而，原料供應波動、與監管合規相關的生產成本以及棕櫚油和大豆油市場的波動等挑戰，可能會影響甘油的價格和供應。

全球藥用甘油市場促進因素

全球藥用甘油市場的主要促進因素之一是藥物製劑中對天然和有機成分日益成長的需求。隨著製藥業日益關注永續性以及消費者對環保產品的偏好，源自可再生資源的甘油因其在藥物、添加劑和防凍劑配方中的廣泛應用而備受關注。此外，甘油的多功能特性，例如作為高效保濕劑、溶劑和甜味劑，使其成為多種藥物產品開發中不可或缺的成分，進一步推動了其廣泛應用和市場成長。

限制全球藥用甘油市場的因素

全球藥用甘油市場面臨的主要限制因素之一是嚴格的法規環境，該環境規範著藥品生產和使用中的甘油。遵守各項國際品質標準和法規對生產商構成重大挑戰，可能導致成本增加和研發週期延長。此外，污染風險以及確保產品純度一致性的要求也限制了產能。這些監管障礙可能阻礙中小企業進入市場，導致整體競爭和創新能力下降，從而阻礙市場成長和擴張。

全球藥用甘油市場趨勢

全球藥用甘油市場正經歷著向植物來源甘油的顯著轉變，這主要得益於消費者對永續和純素產品日益成長的需求。這一趨勢反映出企業普遍致力於符合道德規範的採購和潔淨標示理念，並優先考慮配方中的透明度和環境責任。天然輔料的應用正在迅速發展，尤其是在歐洲和北美等關鍵地區，而鼓勵使用永續成分的監管標準的不斷改進也進一步加速了這一趨勢。隨著人們對植物來源替代品益處的認知不斷提高，預計市場將繼續擴張，從而推動創新應用和配方的開發。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

IOI Oleo GmbH（Germany）
Archer Daniels Midland Company（ADM）（United States）
KLK Oleo（Malaysia）
Oleon NV（Belgium）
Dow, Inc.（United States）
Cargill, Incorporated（United States）
Emery Oleochemicals（Malaysia）
P&G Chemicals（United States）
Wilmar International Limited（Singapore）
The Chemical Company（TCC）（United States）
Godrej Industries Limited（India）
Twin Rivers Technologies, Inc.（United States）
VVF LLC（India）
Avril Group（France）
GLACONCHEMIE GmbH（Germany）
Croda International Plc（United Kingdom）
Rajaram Solvents Pvt. Ltd.（India）
3F Chimica SpA（Italy）
Solvay SA（Belgium）
Peter Greven GmbH & Co. KG（Germany）

結論與建議

簡介目錄

Product Code: SQMIG35I2481

Global Pharmaceutical Glycerine Market size was valued at USD 38.5 million in 2024 and is poised to grow from USD 41.08 million in 2025 to USD 69.01 million by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global pharmaceutical glycerine market is witnessing significant growth driven by its expanding applications in drug formulations, including capsules, syrups, and topical products, owing to its safety and versatility. The rising demand for cough syrups, wound care ointments, and glycerine-based capsules in emerging markets is fueling consumption. This growth is also bolstered by advancements in the pharmaceutical sector, particularly in the Asia-Pacific and Latin America regions, alongside improvements in manufacturing processes that yield higher purity glycerine. The increasing preference for plant-derived glycerine is further supporting the shift towards sustainable bio-based materials. However, challenges such as raw material supply fluctuations, production costs due to regulatory compliance, and disruptions in the palm oil and soybean oil markets may impact pricing and availability.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glycerine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glycerine Market Segments Analysis

Global Pharmaceutical Glycerine Market is segmented by Type, Source, Application and region. Based on Type, the market is segmented into 99.7% Purity and Above 99.7% Purity. Based on Source, the market is segmented into Animal and Plant. Based on Application, the market is segmented into Oral Use and External use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glycerine Market

One of the key market drivers for the global pharmaceutical glycerine market is the rising demand for natural and organic ingredients in drug formulations. As the pharmaceutical industry increasingly focuses on sustainability and consumer preferences for eco-friendly products, glycerine, derived from renewable sources, is gaining traction for its diverse applications in medicines, excipients, and antifreeze formulations. Additionally, glycerine's multifunctional properties, such as being an effective humectant, solvent, and sweetening agent, make it an essential component in the development of various pharmaceutical products, further boosting its utilization and driving market growth.

Restraints in the Global Pharmaceutical Glycerine Market

One key market restraint for the Global Pharmaceutical Glycerine Market is the stringent regulatory environment governing the production and use of glycerine in pharmaceuticals. Compliance with varied international quality standards and regulations can pose significant challenges for manufacturers, leading to increased costs and longer development timelines. Additionally, the potential for contamination and the need for consistent product purity can limit production capabilities. These regulatory hurdles can deter small and medium-sized enterprises from entering the market, thus reducing overall competition and innovation, ultimately hindering market growth and expansion.

Market Trends of the Global Pharmaceutical Glycerine Market

The global pharmaceutical glycerine market is witnessing a significant shift towards plant-based glycerine, fueled by increasing consumer demand for sustainable and vegan-friendly products. This trend reflects a broader commitment to ethical sourcing and clean-label initiatives, as companies prioritize transparency and environmental responsibility in their formulations. The rise of regulatory standards favoring sustainable ingredients further amplifies this movement, particularly in key regions like Europe and North America, where the adoption of natural excipients is rapidly gaining momentum. As awareness of the benefits of plant-derived alternatives continues to grow, the market is expected to expand, leading to innovative applications and formulations.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Pharmaceutical Glycerine Market Size by Type & CAGR (2026-2033)

Market Overview
99.7% Purity
Above 99.7% Purity

Global Pharmaceutical Glycerine Market Size by Source & CAGR (2026-2033)

Market Overview
Animal
Plant

Global Pharmaceutical Glycerine Market Size by Application & CAGR (2026-2033)

Market Overview
Oral Use
External use

Global Pharmaceutical Glycerine Market Size & CAGR (2026-2033)

North America (Type, Source, Application)
- US
- Canada
Europe (Type, Source, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Source, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Source, Application)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Source, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

IOI Oleo GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Archer Daniels Midland Company (ADM) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KLK Oleo (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oleon NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dow, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cargill, Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emery Oleochemicals (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
P&G Chemicals (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wilmar International Limited (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Chemical Company (TCC) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Godrej Industries Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twin Rivers Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VVF LLC (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avril Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GLACONCHEMIE GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Croda International Plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rajaram Solvents Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3F Chimica SpA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solvay SA (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Peter Greven GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments